Product
BSI-045B
2 clinical trials
1 indication
Indication
Atopic DermatitisClinical trial
A Phase 2a, Multicenter, Proof-of-Concept Clinical Trial to Evaluate Efficacy and Safety of BSI-045B mAb Injection as Monotherapy or Add-on Therapy With Dupilumab in Patients With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-11-18
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate Safety and Tolerability of BSI-045B mAb Injection in Healthy Adult Subjects and Patients With Atopic DermatitisStatus: Completed, Estimated PCD: 2023-02-15